Merger Links

REATA PHARMACEUTICALS INC

REATA PHARMACEUTICALS INC

SUMMARY

Reata Pharmaceuticals is a pharmaceutical company based in Plano, Texas. Founded in 2002, Reata is primarily focused on investigating experimental oral antioxidative and anti-inflammatory drugs.

DEALS OVERVIEW

Deals (2)Service Providers Relationships Portfolio Team
11/06/2020United States
Pharmaceuticals
AcquisitionPrivate EquityDomesticPublicMinority
Reata Pharmaceuticals

target

Reata Pharmaceuticals

Blackstone Group

bidder

Blackstone Group

£280m

34 dealmakers

28/07/2023United States
Pharmaceuticals
AcquisitionMajorityDomesticPublic
Reata Pharmaceuticals

target

Reata Pharmaceuticals

Biogen

bidder

Biogen

£5,690m

55 dealmakers

Sign up for a free trial account to enjoy the full Mergerlinks experience
Identify industry experts, connect with verified professionals, forge new relationships.
Sign Up
11/06/2020United States
Pharmaceuticals
AcquisitionPrivate EquityDomesticPublicMinority
Reata Pharmaceuticals

target

Reata Pharmaceuticals

Blackstone Group

bidder

Blackstone Group

£280m

34 dealmakers

11/06/2020United States
Pharmaceuticals
AcquisitionPrivate EquityDomesticPublicMinority
Reata Pharmaceuticals

target

Reata Pharmaceuticals

Blackstone Group

bidder

Blackstone Group

£280m

34 dealmakers

11/06/2020United States
Pharmaceuticals
AcquisitionPrivate EquityDomesticPublicMinority
Reata Pharmaceuticals

target

Reata Pharmaceuticals

Blackstone Group

bidder

Blackstone Group

£280m

34 dealmakers

11/06/2020United States
Pharmaceuticals
AcquisitionPrivate EquityDomesticPublicMinority
Reata Pharmaceuticals

target

Reata Pharmaceuticals

Blackstone Group

bidder

Blackstone Group

£280m

34 dealmakers

11/06/2020United States
Pharmaceuticals
AcquisitionPrivate EquityDomesticPublicMinority
Reata Pharmaceuticals

target

Reata Pharmaceuticals

Blackstone Group

bidder

Blackstone Group

£280m

34 dealmakers

MERGERLINKS LIMITED • 15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM • CONTACT@MERGERLINKS.COM

© COPYRIGHT 2023 MERGERLINKS.COM. ALL RIGHTS RESERVED.